TF Market Research



Title:

KWANG-DONG PHARMACEUTICAL CO., LTD-COMPANY INSIGHT

Price:$320.00
Publication Date:Jul 14, 2008
Source:LIFE SCIENCE ANALYTICS
Author:HARINATHA, G.
Brief Excerpt:...Kwang-Dong Pharmaceutical Co., Ltd is a healthca re company engaged in the manufacture of herbal medicines and related products. The company was founded in #### by Soo B. Choi . Its subsidiaries include Kwang Dong Household and Healthcare Inc. and Kwang-Dong Oriental Hospital. Kwang-Dong Pharmaceutical product folio includes OTC, Prescripti on drugs and Active pharmaceutic ingredients, Drinks, Functional food, Traditional health food and others. Its products includes Derma-K(sodium fusidate-moisture dressing), Hythiol-c Premier for skin disorders, Powe racen for constipation, MAZANOR [Mazanol(Mazindol)] for weight loss, Doxifluridine capsule for cancer, B eauracen(Human placenta extract) for symptom relief of climacteric malfunctions, Copolang capsule for cancers, compound drinks, Ginseng drinks, Uni-calcium Gold, kwang-dong Gamma Linolenic Acid Gold, New Chitoo ligosaccharide Alpha, Cervi Pantotrichum Cornu Energy Drink, Kwang dong red ginseng antler won(health food), Kwang...
Length:9 Pages (8 Billable Pages)
Company:KWANG DONG PHARMACEUTICAL CO LTD
Geographic Regions:ASIA, EASTERN ASIA, KOREA, REPUBLIC OF
Non-Billable Page Numbers:2
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Company Information11
Kwang-Dong Pharmaceutical Co., Ltd [NonUS -- Symbol : Stock Code Number : 009290 (KSC)]11
Formation Date: 196311
Business Summary11
Product Glance31
No of Products31
Trial Phase31
Diseasehub Classification31
Product Summary41
Condition Treated41
Trial Phase Source Partner41
Products41
Product Details41
1. Pyeon ja pill Disease Hub Description51
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 2. Copolang Disease Hub Description51
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 3. Venitol Disease Hub Description51
Therapeutic Indication Cancer Current Trial M Trial Details Presently it is Last Updated 5/7/2008 5. Tamoxifen KWANG DONG Dis51
Therapeutic Indication Current Trial Trial Details Last Updated 6. Teroful Disease Hub Description51
Therapeutic Indication Drug Class Current Trial M Trial Details Last Updated 7. Chito acid 100Q Disease Hub Description Chito61
Therapeutic Indication Natural immune Current Trial M Trial Details Presently it is Last Updated 4/14/2008 8.2, 4 Diet Fiben61
Therapeutic Indication Current Trial Trial Details Last Updated 9. Sencodyl Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 10. Poweramin Disease Hub Description61
Therapeutic Indication Current Trial M Trial Details Last Updated 11. Hardy col plus Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated71
Corporate Partners81
Deal Category: Product Date Source81
Deal Value (in $ MM)81
Management Profile91
Soo Boo Choi -- Chairman and Chief Executive Officer91
Sung Won Cho -- President and Director91
Hyun Shik Kim -- Managing Director91
Yong Gwang Lee -- Managing Director91
Gwa Gyoon Moh -- Managing Director91
Tables
TitleStarting PageNumber of Pages
of Contents21

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $320.00

Looking For Something Else?





TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

  about us | contact us | public company index | private company index | pcan | widget | your privacy rights | terms & conditions  

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.